Track Order   | Customer Support   | Request Book   |
International Order
Proteasome Inhibitors In Cancer Therapy at Meripustak

Proteasome Inhibitors In Cancer Therapy

Books from same Author: Adams Julia

Books from same Publisher: Springer

Related Category: Author List / Publisher List

  • Retail Price: ₹ 20059/- [ 5.00% off ]

    Seller Price: ₹ 19056

Sold By: T K Pandey      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 5.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 5.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available


Click for International Orders
  • Provide Fastest Delivery
  • 100% Original Guaranteed
    • General Information  
    Author(s)Adams Julia
    PublisherSpringer
    EditionEdition Statement 2004 ed.
    ISBN9781588292506
    Pages313
    BindingHard Binding
    LanguageEnglish
    Publish YearJuly 2004

    Description

    Springer Proteasome Inhibitors In Cancer Therapy by Adams Julia

    A Panel Of Leading Academic And Pharmaceutical Investigators Takes Stock Of The Remarkable Work That Has Been Accomplished To Date With Proteasome Inhibitors In Cancer And Examines Emerging Therapeutic Possibilities. The Topics Range From A Discussion Of The Chemistry And Cell Biology Of The Proteasome And The Rationale For Proteasome Inhibitors In Cancer To A Review Of Current Clinical Trials Underway. The Discussion Of Rationales For Testing Proteasome Inhibitors In Cancer Models Covers The Role Of The Proteasome In Nf-Kb Activation The Combining Of Conventional Chemotherapy And Radiation With Proteasome Inhibition Notably Ps-341 New Proteasome Methods Of Inhibiting Viral Maturation And The Role Of Protesome Inhibition In The Treatment Of Aids. The Authors Also Document The Development Of Bortezomib (Velcade (Tm)) In Phase I Clinical Trials And In A Multicentered Phase Ii Clinical Trials In Patients With Relapsed And Refractory Myeloma.Show More